Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01486654 · ClinicalTrials.gov registry record · Phase 1

Transcranial Direct Current Stimulation and Aphasia Language Therapy

A Phase 1 study, sponsored by Shirley Ryan AbilityLab.

Completed
Registry status
Phase 1
Development phase
12
Enrollment target

NCT01486654 is a Phase 1 study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01486654, a Phase 1 study, has completed, sponsored by Shirley Ryan AbilityLab.

COMPLETED
Registry status
Phase 1
Development phase
12 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the effectiveness of small amounts of electrical current, applied without surgery to the brain, in combination with speech-language treatment, on the language outcome of study subjects with nonfluent aphasia (i.e. difficulty with the comprehension and expression of spoken and written language) following a stroke.

Interventions

  • DEVICE Transcranial Direct Current Stimulation - Cathodal stimulation
  • DEVICE Transcranial Direct Current Stimulation - Anodal stimulation
  • DEVICE Transcranial Direct Current Stimulation - Sham stimulation

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2010-03
Est. Completion 2016-12
Phase Phase 1

Sponsor

Shirley Ryan AbilityLab

138 total trials

What the Registry Record Tells You About NCT01486654

The ClinicalTrials.gov registry entry for NCT01486654 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Transcranial Direct Current Stimulation - Cathodal stimulation is the first listed.

NCT01486654 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01486654 about?

NCT01486654 is a clinical study titled "Transcranial Direct Current Stimulation and Aphasia Language Therapy". The purpose of this study is to evaluate the effectiveness of small amounts of electrical current, applied without surgery to the brain, in combination with speech-language treatment, on the language outcome of study subjects with nonfluent aphasia (i.e. difficulty with the comprehension and express...

What is the current status of trial NCT01486654?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2010-03. Estimated completion is 2016-12.

What interventions are being tested in trial NCT01486654?

The interventions under investigation include: Transcranial Direct Current Stimulation - Cathodal stimulation (DEVICE), Transcranial Direct Current Stimulation - Anodal stimulation (DEVICE), Transcranial Direct Current Stimulation - Sham stimulation (DEVICE).

Who is sponsoring clinical trial NCT01486654?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.